{"id":"W3203864709","doi":"10.1200/jco.21.00838","title":"Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Royal Victoria Regional Health Centre; Ottawa Hospital; Royal Victoria Hospital; University of Ottawa","funders":"National Cancer Institute; Pharmacyclics","keywords":"Rituximab; Medicine; Ibrutinib; Internal medicine; Placebo; Waldenstrom macroglobulinemia; Clinical endpoint; Adverse effect; Regimen; Gastroenterology; Surgery; Oncology; Randomized controlled trial; Lymphoma; Chronic lymphocytic leukemia; Leukemia; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01576093,0.0004243507,0.00750292,0.0002981349,0.0002278886,0.00008649318,0.0007733982,0.0007648757,0.0009937908],"category_scores_gemma":[0.03290927,0.0002631573,0.002940807,0.001399187,0.0009171366,0.000143439,0.0004154134,0.002682986,0.00005535776],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.006789547,"about_ca_system_score_gemma":0.05198501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000766091,"about_ca_topic_score_gemma":0.0007620042,"domain_scores_codex":[0.9880322,0.002883587,0.006058122,0.0007276139,0.001499266,0.0007991765],"domain_scores_gemma":[0.9490152,0.04404869,0.002645102,0.0009818192,0.002653794,0.00065541],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9219748,0.0100431,0.0002113963,0.00003522829,0.01927054,0.008884718,0.0006001784,0.0003488899,0.00004293863,0.0001081494,0.008602371,0.02987764],"study_design_scores_gemma":[0.9220491,0.009274486,0.000264637,0.00007394757,0.01687291,0.0005470698,0.001899667,0.03623769,0.0001212006,0.0001622076,0.01227063,0.0002264803],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9740515,0.00175393,0.004586172,0.01337313,0.002877261,0.002238478,0.00007942801,0.00002895212,0.001011193],"genre_scores_gemma":[0.9853892,0.000643477,0.006700195,0.002098182,0.003982396,0.00008195826,0.00009869725,0.0000496606,0.0009561819],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04519546,"threshold_uncertainty_score":0.9999821,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2018638911413591,"score_gpt":0.5228453159033778,"score_spread":0.3209814247620187,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}